Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiviral therapy.

H Stalder

    The Yale Journal of Biology and Medicine
    |September 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    This review covers antiviral therapies, discussing challenges like drug toxicity and diagnosis delays. It highlights current and future possibilities for effective antiviral treatments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mucosal lesions in a sheep infected with the Border Disease Virus (BDV).

    Schweizer Archiv fur Tierheilkunde·2009
    Same author

    Missed appointments at a Swiss university outpatient clinic.

    Public health·2007
    Same author

    [Fever and weight loss in a 57-year-old patient].

    Revue medicale suisse·2007
    Same author

    [A physician reflects after 20 years of practice].

    Revue medicale suisse·2006
    Same author

    [General practice--linear thinking and complexity].

    Revue medicale suisse·2006
    Same author

    [Quality care in primary care: the importance of patients' reports].

    Revue medicale suisse·2006
    Same journal

    Chrysoeriol-Mediated Neuroprotection in Parkinson's Disease in Mice: Targeting Apoptosis, α-Synuclein Accumulation, and Functional Recovery.

    The Yale journal of biology and medicine·2026
    Same journal

    Musicality is Preserved in Neurodegeneration.

    The Yale journal of biology and medicine·2026
    Same journal

    Burden of Neurological Disorders in Resource-Limited Settings: Lessons from Pakistan for Global Neurology.

    The Yale journal of biology and medicine·2026
    Same journal

    Comparative Analysis of Prenatal Stress Models: Placental and Neurodevelopmental Outcomes in Mice.

    The Yale journal of biology and medicine·2026
    Same journal

    Computational Investigation of Flavonoid-Associated Molecular Pathways in Astrogliosis Modulation.

    The Yale journal of biology and medicine·2026
    Same journal

    Regulation and Interaction Among SOCS1 and SOCS3 by MicroRNAs in Multiple Sclerosis: A Review and <i>In Silico</i> Analysis.

    The Yale journal of biology and medicine·2026
    See all related articles

    Area of Science:

    • Virology
    • Pharmacology
    • Infectious Diseases

    Background:

    • Viral diseases pose significant health challenges.
    • Antiviral therapy development has faced numerous obstacles.
    • Understanding pathophysiological aspects is crucial for treatment.

    Purpose of the Study:

    • To review the current status of antiviral therapy.
    • To discuss challenges hindering progress in antiviral drug development.
    • To present a guide on the indications and application of antiviral treatments.

    Main Methods:

    • Comprehensive review of existing literature on antiviral therapies.
    • Discussion of older and newer chemotherapy approaches.
    • Analysis of clinically tested antiviral substances.

    Related Experiment Videos

    Main Results:

    • Identified key challenges: intracellular penetration, drug toxicity, narrow spectrum, diagnostic delays, and evaluating treatment effects.
    • Reviewed various antiviral agents including immunoglobulins, synthetic drugs (amantadine, nucleoside analogs), and interferon.
    • Presented a guide for clinical indications and application of antiviral therapy.

    Conclusions:

    • Despite current limitations and few indications, antiviral therapy holds future potential.
    • Clinicians must be aware of the evolving possibilities in antiviral treatment.
    • Continued research is essential to overcome existing challenges in antiviral drug development.